Long-term clinical follow-up of intracranial aneurysms treated with flow diverter devices: a bicentric retrospective study
Open Access
- 20 March 2026
- journal article
- research article
- Published by Springer Nature in Chinese Neurosurgical Journal
- Vol. 12 (1) , 10
Abstract
Background: Flow diverter devices (FDDs) have revolutionized the treatment of intracranial aneurysms. However, comprehensive long-term outcome data across multiple device platforms remain limited, with most prior studies focusing exclusively on Pipeline embolization device (PED) outcomes. This study reports extensive long-term clinical follow-up of patients treated with various types of FDDs, providing critical safety and efficacy data for contemporary practice. Methods: We conducted a retrospective analysis of intracranial aneurysms treated with FDDs from February 2011 to July 2016 in two tertiary care centers in France. The study included 209 patients with 216 cerebral aneurysms (91.2% anterior circulation, 8.8% posterior circulation; 66.2% unruptured, 31.0% recanalized, 2.8% ruptured). The duration of clinical and angiographic follow-up ranged from 24 to 156 months. Kaplan–Meier analysis performed for complication-free survival and aneurysm occlusion durability. Multivariate analysis showed risk factors for delayed complications. Results: Long-term follow-up data were available for 202/209 (96.7%) patients. The early permanent morbidity and mortality rates were 3.8% and 1.4%, respectively. Between 12 and 18 months, procedure-related complications occurred in 5 of 202 patients (2.5%): two ischemic events, one delayed rupture, one silent intrastent stenosis, and one case of seizures following antiplatelet withdrawal. Only three patients (1.5%) were symptomatic. At the 24-month follow-up, complete aneurysm occlusion achieved in 81.0% of the patients, with adequate occlusion in 93.3%. Kaplan–Meier analysis revealed 97.5% complication-free survival at 18 months, with sustained durability thereafter. Multiple FDDs were the only significant independent predictor of delayed complications (OR: 7.066, 95% CI: 1.049–47.606, P < 0.045). No procedure-related complications or deaths occurred after 18 months. Conclusion: Beyond 18 months of follow-up, FDD treatment for intracranial aneurysms proves exceptional safety with no delayed complications, regardless of device type. However, the findings of this study also show 18 months as a critical threshold for complication risk assessment, a key implication that clinicians and researchers need to be aware of. The study also underscores the need for modified management strategies when multiple overlapping FDDs are deployed, which significantly increases the risk of delayed complications.Keywords
This publication has 15 references indexed in Scilit:
- Safety and efficacy profile of off-label use of the Pipeline Embolization Device: A systematic review and meta-analysisJournal of Stroke and Cerebrovascular Diseases, 2024
- In-Pipeline StenosisNeurosurgery, 2015
- Delayed hemorrhagic complications after flow diversion for intracranial aneurysms: a literature overviewNeuroradiology, 2015
- Concurrent use of the Pipeline Embolization Device and coils for intracranial aneurysms: technique, safety, and efficacyJournal of Neurosurgery, 2015
- Periprocedural and mid-term technical and clinical events after flow diversion for intracranial aneurysmsJournal of NeuroInterventional Surgery, 2014
- Panacea or problem: flow diverters in the treatment of symptomatic large or giant fusiform vertebrobasilar aneurysmsJournal of Neurosurgery, 2012
- Flow Diversion for Intracranial AneurysmsStroke, 2011
- A Novel Grading Scale for the Angiographic Assessment of Intracranial Aneurysms Treated Using Flow Diverting StentsInterventional Neuroradiology, 2010
- International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusionThe Lancet, 2005
- Endovascular Treatment of Unruptured AneurysmsStroke, 2001